Zimmer Biomet Holdings, Inc. ZBH recently received ... Oxford Cementless Partial Knee has become the only FDA-approved cementless partial knee implant in the United States. The latest FDA PMA ...

Zimmer Biomet Holdings ... a total knee implant component, and FDA’s premarket application supplement approval for the Oxford Cementless Partial Knee. These developments might have had a ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...

Zimmer Biomet expressed its optimism ... include the Persona Revision Knee System, the HAMMR Automated Hip Impaction System, and the Oxford Cementless Partial Knee System. Tornos said: “We ...

Zimmer Biomet's Q4 2024 revenue increased by 4.3% year-over-year. The company launched significant new products, including the Oxford Partial Cementless Knee. Zimmer Biomet anticipates 3-5% ...